Currently a nationwide expanded access program is in place designed to recruit plasma donors and use the valuable blood component as part of the treatment protocol for COVID-19 patients. A single plasma donation can be used for multiple patients. Those who have completely recovered from COVID-19 may have immune-boosting antibodies in their blood which could be used to treat critically ill COVID-19 patients.
The Food and Drug Administration allows the transfusion of convalescent plasma as an investigational treatment. It’s one of the antibody treatments available for COVID-19 patients.
Current eligibility criteria for plasma donation include:
Please note that if you have received the COVID-19 vaccine or participated in a COVID-19 vaccine trial, you are currently not eligible to donate convalescent plasma.